2016
DOI: 10.1016/j.ando.2016.04.014
|View full text |Cite
|
Sign up to set email alerts
|

Prokineticin1 and pregnancy

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
9
0

Year Published

2020
2020
2023
2023

Publication Types

Select...
6

Relationship

1
5

Authors

Journals

citations
Cited by 11 publications
(10 citation statements)
references
References 42 publications
1
9
0
Order By: Relevance
“…Recent studies from our own group and from others demonstrated that increased expression of EG-VEGF is associated with PE and FGR development (Hoffmann et al, 2006;Alfaidy, 2016;Inan et al, 2018). Our group also demonstrated that the concentration of EG-VEGF is significantly increased in both pathologies (Hoffmann et al, 2006;Murthi et al, 2015;Alfaidy, 2016). More recently, a study confirmed the increase in EG-VEGF levels in PE and proposed this factor as a biomarker for the diagnosis of PE patients (Inan et al, 2018).…”
Section: Prokineticins Expression In Micro-and Macrovascular Placentasupporting
confidence: 74%
See 1 more Smart Citation
“…Recent studies from our own group and from others demonstrated that increased expression of EG-VEGF is associated with PE and FGR development (Hoffmann et al, 2006;Alfaidy, 2016;Inan et al, 2018). Our group also demonstrated that the concentration of EG-VEGF is significantly increased in both pathologies (Hoffmann et al, 2006;Murthi et al, 2015;Alfaidy, 2016). More recently, a study confirmed the increase in EG-VEGF levels in PE and proposed this factor as a biomarker for the diagnosis of PE patients (Inan et al, 2018).…”
Section: Prokineticins Expression In Micro-and Macrovascular Placentasupporting
confidence: 74%
“…Since its identification EG-VEGF has been associated with the control of placental angiogenesis during the first trimester of pregnancy and the reactivation of its receptors in the placenta of patients with pregnancy pathologies such as PE and FGR (Brouillet et al, 2010(Brouillet et al, , 2012a(Brouillet et al, , 2013a(Brouillet et al, , 2014aGarnier et al, 2015;Alfaidy, 2016;Sergent et al, 2016). The reactivation of angiogenic processes was meant to compensate for the associated deleterious vascularization.…”
Section: Key Regulators Of Prokineticins For Successful Placental Angmentioning
confidence: 99%
“…In the formation of the capillary network in the placenta, one of the most important processes is angiogenesis, i.e., the process of new blood vessel formation from pre-existing blood vessels. Angiogenesis is tightly controlled by numerous angiogenic regulators, the most common of which are VEGFA, FGF2, ANGPT1, and ANGPT2 33 ; however, recent studies have shown an emerging role of PROK1 during pregnancy 7 9 , 12 . Our previous study has demonstrated that PROK1 is involved in endometrial angiogenesis by the stimulating endothelial cell proliferation and network formation and by increasing the secretion of VEGFA and PGF2α 7 .…”
Section: Discussionmentioning
confidence: 99%
“…Interestingly, in human trophoblast cells, PROKR1 mRNA expression has been found to be 80 times higher when compared to the expression of PROKR2 mRNA 11 . Besides angiogenesis, PROK1 may regulate a number of biological processes, including cell–cell contact, cell migration, proliferation, and inflammatory response 7 , 8 , 12 . Our recent study revealed that PROK1 could be an embryonic signal mediator which, acting via PROKR1, stimulates angiogenesis in the porcine endometrium during implantation and the early placentation period 7 .…”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation